{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T09:48:02Z","timestamp":1777196882619,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["05-064"],"award-info":[{"award-number":["05-064"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1053\/beem.2000.0087","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:54:50Z","timestamp":1032429290000},"page":"399-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Assessment of seminiferous tubule function (anti-m\u00fcllerian hormone)"],"prefix":"10.1053","volume":"14","author":[{"given":"Rodolfo","family":"Rey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beem.2000.0087_RF1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-3782(93)90204-8","article-title":"Anti-M\u00fcllerian hormone in early human development","volume":"33","author":"Josso","year":"1993","journal-title":"Early Human Development"},{"key":"10.1053\/beem.2000.0087_RF2","first-page":"3836","article-title":"Expression of anti-M\u00fcllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells","volume":"84","author":"Rajpert-De Meyts","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0087_RF3","first-page":"1689","article-title":"Testicular dysgenesis does not affect expression of anti-m\u00fcllerian hormone by Sertoli cells in premeiotic seminiferous tubules","volume":"148","author":"Rey","year":"1996","journal-title":"American Journal of Pathology"},{"key":"10.1053\/beem.2000.0087_RF4","first-page":"540","article-title":"Detection of minimal levels of serum anti-M\u00fcllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay","volume":"85","author":"Long","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0087_RF5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1101\/gad.13.7.755","article-title":"Mammalian sex determination: a molecular drama","volume":"13","author":"Swain","year":"1999","journal-title":"Genes and Development"},{"key":"10.1053\/beem.2000.0087_RF6","first-page":"627","article-title":"Evaluation of gonadal function in 107 intersex patients by means of serum antim\u00fcllerian hormone measurement","volume":"84","author":"Rey","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0087_RF7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/9629","article-title":"A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans","volume":"22","author":"Achermann","year":"1999","journal-title":"Nature Genetics"},{"key":"10.1053\/beem.2000.0087_RF8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/hmg\/6.1.91","article-title":"Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype-phenotype correlations","volume":"6","author":"Meyer","year":"1997","journal-title":"Human Molecular Genetics"},{"key":"10.1053\/beem.2000.0087_RF9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1172\/JCI119653","article-title":"Hormonal and cellular regulation of Sertoli cell anti-M\u00fcllerian hormone production in the postnatal mouse","volume":"100","author":"Al-Attar","year":"1997","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beem.2000.0087_RF10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/humrep\/14.1.136","article-title":"Reversion of the differentiated phenotype and maturation block in Sertoli cells in pathological human testis","volume":"14","author":"Steger","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1053\/beem.2000.0087_RF11","first-page":"571","article-title":"Mullerian inhibiting substance in humans: normal levels from infancy to adulthood","volume":"81","author":"Lee","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0087_RF12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0022-5347(01)64569-5","article-title":"Serum levels of m\u00fcllerian inhibiting substance in preterm and term male neonates","volume":"158","author":"Schwindt","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1053\/beem.2000.0087_RF13","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/humrep\/14.8.2020","article-title":"Anti-M\u00fallerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia","volume":"14","author":"F\u00e9nichel","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1053\/beem.2000.0087_RF14","first-page":"1220","article-title":"Anti-m\u00fcllerian hormone and testosterone serum levels are inversely related during normal and precocious pubertal development","volume":"77","author":"Rey","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0087_RF15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2265.1981.tb00700.x","article-title":"Testicular testosterone levels during puberty in cryptorchidism","volume":"15","author":"Pasqualini","year":"1981","journal-title":"Clinical Endocrinology"},{"key":"10.1053\/beem.2000.0087_RF16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000184300","article-title":"Paediatric applications of anti-M\u00fcllerian hormone research","volume":"43","author":"Josso","year":"1995","journal-title":"Hormone Research"},{"key":"10.1053\/beem.2000.0087_RF17","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199705223362102","article-title":"Measurements of serum Mullerian inhibiting substance in the evaluation of children with nonpalpable gonads","volume":"336","author":"Lee","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beem.2000.0087_RF18","series-title":"Endocrinology","first-page":"1901","article-title":"Diagnosis and treatment of disorders of sexual development","author":"Forest","year":"1994"},{"key":"10.1053\/beem.2000.0087_RF19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2265.1997.2411044.x","article-title":"Clinical aspects and molecular genetics of the persistent m\u00fcllerian duct syndrome","volume":"47","author":"Josso","year":"1997","journal-title":"Clinical Endocrinology"},{"key":"10.1053\/beem.2000.0087_RF20","first-page":"2696","article-title":"Antim\u00fcllerian hormone in patients with hypogonadotropic hypogonadism","volume":"84","author":"Young","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0087_RF21","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1093\/oxfordjournals.humrep.a019070","article-title":"The presence of m\u00fcllerian inhibiting substance in human seminal plasma","volume":"11","author":"Fallat","year":"1996","journal-title":"Human Reproduction"},{"key":"10.1053\/beem.2000.0087_RF22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0022-3476(96)70040-9","article-title":"Immunoreactive inhibin, mullerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumors","volume":"129","author":"Silverman","year":"1996","journal-title":"Journal of Pediatrics"},{"key":"10.1053\/beem.2000.0087_RF23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0046-8177(98)90454-3","article-title":"M\u00fcllerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors","volume":"29","author":"Mat\u0131\u0301as Guiu","year":"1998","journal-title":"Human Pathology"},{"key":"10.1053\/beem.2000.0087_RF24","doi-asserted-by":"crossref","DOI":"10.1053\/hupa.2000.18498","article-title":"Anti-M\u00fcllerian hormone is a specific marker of Sertoli- and granulosa-cell origin in gonadal tumors","author":"Rey","year":"2000","journal-title":"Human Pathology"},{"key":"10.1053\/beem.2000.0087_RF25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/gyno.1998.5290","article-title":"Diagnostic utility of Mullerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors","volume":"73","author":"Lane","year":"1999","journal-title":"Gynecologic Oncology"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X00900873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X00900873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:32:23Z","timestamp":1761496343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X00900873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S1521690X00900873"],"URL":"https:\/\/doi.org\/10.1053\/beem.2000.0087","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of seminiferous tubule function (anti-m\u00fcllerian hormone)","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/beem.2000.0087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Harcourt Publishers Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}